The U.S. health regulator asked drugmakers on Tuesday to remove warnings about a potential risk of suicidal thoughts from ...

The Food and Drug Administration approved on Friday a label change for Pfizer's birth control shot Depo-Provera that warns patients of the risk of meningioma, a tumor in the lining of the brain.

From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or ...

BOGOTA, Colombia (AP) — The Trump administration on Tuesday designated another Latin American drug cartel as a foreign terrorist organization, increasing financial pressure on its members and opening ...

CLEVELAND — The Food and Drug Administration has approved expanded use of Addyi, a medication designed to address low sexual desire in women, now including post-menopausal women under age 65. Sprout ...

AstraZeneca and Daiichi Sankyo got U.S. approval to expand the label of their jointly developed Enhertu drug in combination with another medicine as an initial treatment for a type of breast cancer.

The federal government urged the US Supreme Court to hear an appeal from Hikma Pharmaceuticals USA Inc. challenging an appeals court ruling that it induced doctors or pharmacists to prescribe its ...

Morning after-pills provide roughly 85 % effective in preventing pregnancy when taken within 72 hours of unprotected intercourse An expert committee under India’s top drug regulator has recommended ...

Before this long shutdown began, many Republicans had already brushed off their oaths of office, allowing President Donald Trump to control Congress [“Senate deal passes, first step toward reopening,” ...

The long-standing FDA warning advised doctors that hormone therapy can increase the risk of blood clots, heart problems and other health issues, citing data published more than 20 years ago.

The Orange Man standing mindlessly while someone is being helped after fainting in the Oval Office is a perfect picture. But I do believe he was having a seizure of some kind. That kind of blank stare ...

A controversial provision of a federal law designed to speed copycat drugs to market and foster competition saved Medicare Part D nearly $15 billion from 2015 to 2021 on just 15 medicines during that ...